VLC
LLY icon

Van Leeuwen & Company’s Eli Lilly LLY Stock Holding History

Van Leeuwen & Company’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$4.39M Buy
5,638
+17
+0.3% +$12.1K 2.22% 12
2023
Q4 		$3.28M Sell
5,621
-907
-14% -$529K 1.91% 14
2023
Q3 		$3.51M Sell
6,528
-1,422
-18% -$733K 2.18% 16
2023
Q2 		$3.67M Sell
7,950
-1,252
-14% -$525K 2.3% 15
2023
Q1 		$3.16M Buy
9,202
+1,312
+17% +$442K 2.12% 15
2022
Q4 		$2.89M Sell
7,890
-209
-3% -$74.1K 2% 20
2022
Q3 		$2.62M Sell
8,099
-3,339
-29% -$1.06M 2.09% 18
2022
Q2 		$3.71M Sell
11,438
-2,910
-20% -$873K 3.11% 9
2022
Q1 		$4.11M Buy
14,348
+2,608
+22% +$671K 3.02% 8
2021
Q4 		$3.24M Buy
+11,740
New +$2.98M 1.82% 19
2020
Q3 		– Sell
-14,943
Closed -$2.45M – 69
2020
Q2 		$2.45M Buy
14,943
+4,074
+37% +$625K 1.9% 19
2020
Q1 		$1.51M Buy
10,869
+7,917
+268% +$1.09M 1.45% 28
2019
Q4 		$388K Buy
+2,952
New +$342K 0.32% 60

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Van Leeuwen & Company's LLY Position: Q1 2024 in Review

Van Leeuwen & Company increased its Eli Lilly (LLY) stake by 0.3% in Q1 2024, buying an estimated $12.1K and bringing the position to 5,638 shares worth $4.39M. The position accounts for 2.22% of the portfolio, ranked #12.

Van Leeuwen & Company first reported a position in LLY in Q4 2019 and has held it in 13 quarters since. 3,461 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Van Leeuwen & Company held 5,638 shares of Eli Lilly worth $4.39M as of Q1 2024.
  • Van Leeuwen & Company bought 17 Eli Lilly shares in Q1 2024, an estimated $12.1K.
  • Eli Lilly made up 2.22% of Van Leeuwen & Company's portfolio in Q1 2024, its #12 holding.
  • Van Leeuwen & Company first reported a position in Eli Lilly in Q4 2019 and has held it in 13 quarters since.
  • 3,461 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Van Leeuwen & Company's 13F filing for Q1 2024, filed 10 May 2024.